Director, Life Sciences Senior Analyst
In May 2020, David was selected as a senior analyst in RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. These senior analysts advise clients on conditions influencing middle market leaders. David’s focus is on the life sciences industry.
Summary of experience
David has more than nine years of corporate finance and capital markets experience supporting debt and equity transactions for various industries including life sciences, technology, telecommunications, renewable energy and consumer products. His experience includes negotiating and facilitating transaction closings for private equity, venture capital and financial institutions across North America.
David is responsible for supporting local and cross-border transactions and leading M&A and capital advisory transactions in the private and public sectors. He focuses on providing advisory services for buy and sell-side mandates, specializing in transaction structuring and closing support. He directly manages the team’s pool of experienced analysts and managers, and leverages the firms full financial service offerings and experience where required.
Professional Affiliations and Credentials
- Board Member of the Calgary Chapter of the Association for Corporate Growth (ACG)
- Level III CFA Candidate
- Bachelor of Commerce, finance, University of Calgary
The technology, media and telecom sectors are playing a crucial role in keeping people connected as the pandemic hobbles the global economy.
We expect the Biden administration will bring heightened oversight of anti-competitive behaviors, and the privacy and security of data.
With the election approaching, RSM is looking at the economic stakes and the key issues for the TMT industry.
Companies must assess whether they are ready to take advantage of all the potential 5G networks could unlock.